METHOD FOR PREDICTING THE NEED TO INCLUDE A GLUTEN-FREE DIET IN A THERAPY REGIMEN OF AUTISM SPECTRUM DISORDERS Russian patent published in 2020 - IPC G01N33/50 A23L33/20 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, particularly to pediatrics. Disclosed is a method for predicting the need to include a gluten-free diet in a therapy of autism spectrum disorders. A regression equation K_{pr(effectivity)} is constructed. If K_{pr(effectivity)} is more than 1.7 conv. units, then gluten-free diet will result in correction of behavioral disorders and gastroenterological disorders. If K_{pr(effectivity)} is less than 0.8 conv. units, the positive dynamics of behavioral disorders and gastroenterological disorders does not occur. For patients in whom only one of the analyzed parameters – either behavioral disorders or gastrosymptoms – has been observed, the coefficient value ranges from 1.7 to 0.8 conv. units.

EFFECT: invention provides the individual quantitative assessment of the gluten-free diet compliance effectiveness before the beginning of the prescription in order to reduce the intensity of gastroenterological and behavioral disorders in children with autism spectrum disorders.

1 cl, 2 ex